Ecolab reported first quarter 2026 revenue of $4.07 billion, up 10% year-over-year, and an adjusted diluted EPS of $1.70, a 13% increase from the prior year. The results featured accelerated organic sales growth of 4% and an expansion in adjusted operating margins, leading the company to reaffirm its full-year outlook.
Key Highlights
- Ecolab maintained its full-year 2026 adjusted EPS guidance of $8.43 to $8.63, representing 12% to 15% growth.
- Adjusted operating income margin expanded by 70 basis points to 16.7%, driven by strong pricing and productivity gains which more than offset higher commodity costs.
- Growth was led by strong performance in its Life Sciences segment, which saw organic sales accelerate to 11%, and Global Pest Elimination, which grew 7% organically.